At a glance
ClinicalIndex Comparison RecordN/ACompleted· 525 enrolled
Drug / intervention
cardiac surgery with CPB useprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
INFLACOR (INFLA-mmation A-fter C-ardiac O-pe-R-ation) - Use of Selected Genetic Variants, Cytokines, and Physiologic Parameters in the Prognosis of Postoperative Complications in Patients Undergoing Cardiopulmonary Bypass Cardiac Surgery
In Brief
An observational study evaluating cardiac surgery with CPB use for Systemic Inflammatory Response Syndrome. Completed, enrolled 525 participants across 1 site.
Detailed Summary
The aim of the study is to evaluate a clinically and economically most effective diagnostic algorithm for prediction of inflammatory response related complications in patients undergoing heart surgery with use of cardiopulmonary bypass.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Inflammatory Response Syndrome
CountriesPoland
CollaboratorsMinistry of Science and Higher Education, Poland
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2009
First PostedNov 2009
Primary CompletionApr 2011
Study CompletionNov 2012
TodayJul 2026
First PostedNov 25, 2009
Enrollment StartOct 1, 2009
Primary CompletionApr 1, 2011
Study CompletionNov 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 16.6 years ago
Interventions
cardiac surgery with CPB useprocedure
cardiac surgery with CPB use or ascending aorta surgery performed with use of cardiopulmonary bypass with or without aortic cross clamping.